Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lakefront Biotherapeutics NV GLPGF

Set alert

Price alert · GLPGF

All alert types
31.95 USD 0.00 0.00%

At close · Oct 30

31.95 Day range 31.95
26.24 52-week range 34.00
YTD
+2.11%
1 year
-4.48%
Open
31.95
Prev close
31.95
Mkt cap
2.11B
Vol
100
Avg vol
3
EPS
10.52
P/E
3.04
More statistics
Low
31.95
High
31.95
Earnings
Aug 10, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GLPGF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

14.57 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A+4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 5

Valuation

P/E 5.5×
FY 2016: 52.3×FY 2017: -32.1×FY 2018: -176×FY 2019: 71.0×FY 2020: -16.8×FY 2021: -25.4×FY 2022: -12.2×FY 2023: 9.5×FY 2024: 23.2×FY 2025: 5.5×
FY 2016 5y median 5.5× FY 2025
P/S 1.6×
FY 2016: 21.8×FY 2017: 29.2×FY 2018: 17.8×FY 2019: 12.6×FY 2020: 10.9×FY 2021: 6.5×FY 2022: 5.3×FY 2023: 8.4×FY 2024: 6.2×FY 2025: 1.6×
FY 2016 5y median 6.2× FY 2025
P/B 0.5×
FY 2016: 3.7×FY 2017: 3.7×FY 2018: 4.2×FY 2019: 3.7×FY 2020: 2.0×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.5×
FY 2016 5y median 0.7× FY 2025
P/FCF -8.3×
FY 2016: 12.0×FY 2017: -24.0×FY 2018: -33.0×FY 2019: 3.4×FY 2020: -10.1×FY 2021: -5.7×FY 2022: -4.9×FY 2023: -4.7×FY 2024: -4.3×FY 2025: -8.3×
FY 2016 5y median -4.9× FY 2025
EV/EBITDA 3.2×
FY 2016: -226×FY 2017: -23.3×FY 2018: -134×FY 2019: 23.1×FY 2020: -10.6×FY 2021: -9.5×FY 2022: 561×FY 2023: 36.4×FY 2024: 38.3×FY 2025: 3.2×
FY 2016 5y median 36.4× FY 2025
EV/Sales 1.5×
FY 2016: 14.3×FY 2017: 20.2×FY 2018: 13.3×FY 2019: 10.4×FY 2020: 6.5×FY 2021: 2.0×FY 2022: 4.3×FY 2023: 7.8×FY 2024: 6.0×FY 2025: 1.5×
FY 2016 5y median 4.3× FY 2025
FCF Yield -12.0%
FY 2016: 8.3%FY 2017: -4.2%FY 2018: -3.0%FY 2019: 29.7%FY 2020: -9.9%FY 2021: -17.7%FY 2022: -20.2%FY 2023: -21.1%FY 2024: -23.5%FY 2025: -12.0%
FY 2016 5y median -20.2% FY 2025

Profitability

Gross Margin 97.3%
FY 2016: -7.8%FY 2017: -71.9%FY 2018: -11.8%FY 2019: 49.4%FY 2020: -9.5%FY 2021: 99.7%FY 2022: 97.6%FY 2023: 85.0%FY 2024: 87.4%FY 2025: 97.3%
FY 2016 5y median 97.3% FY 2025
Operating Margin 42.2%
FY 2016: -8.9%FY 2017: -70.7%FY 2018: -15.5%FY 2019: 43.8%FY 2020: -37.4%FY 2021: -34.2%FY 2022: -52.9%FY 2023: -36.8%FY 2024: -68.3%FY 2025: 42.2%
FY 2016 5y median -36.8% FY 2025
Net Margin 28.9%
FY 2016: 41.7%FY 2017: -91.0%FY 2018: -10.1%FY 2019: 17.7%FY 2020: -65.1%FY 2021: -25.9%FY 2022: -43.1%FY 2023: 88.3%FY 2024: 26.9%FY 2025: 28.9%
FY 2016 5y median 26.9% FY 2025
ROE 9.9%
FY 2016: 7.1%FY 2017: -11.4%FY 2018: -2.4%FY 2019: 5.2%FY 2020: -11.6%FY 2021: -4.7%FY 2022: -8.6%FY 2023: 7.6%FY 2024: 2.6%FY 2025: 9.9%
FY 2016 5y median 2.6% FY 2025
ROIC 14.4%
FY 2016: -1.2%FY 2017: -8.1%FY 2018: -3.7%FY 2019: 6.7%FY 2020: -3.5%FY 2021: -3.6%FY 2022: -6.3%FY 2023: 1.6%FY 2024: -2.1%FY 2025: 14.4%
FY 2016 5y median -2.1% FY 2025
ROA 9.4%
FY 2016: 5.0%FY 2017: -9.0%FY 2018: -2.0%FY 2019: 2.5%FY 2020: -5.4%FY 2021: -2.4%FY 2022: -4.6%FY 2023: 4.9%FY 2024: 1.8%FY 2025: 9.4%
FY 2016 5y median 1.8% FY 2025

Growth (YoY)

Revenue 303.4%
FY 2016: 227.4%FY 2017: -1.9%FY 2018: 127.3%FY 2019: 192.5%FY 2020: -43.4%FY 2021: 1.4%FY 2022: 4.2%FY 2023: -52.6%FY 2024: 15.0%FY 2025: 303.4%
FY 2016 FY 2025
Operating Income 349.3%
FY 2016: 87.2%FY 2017: -681.5%FY 2018: 50.1%FY 2019: 926.4%FY 2020: -148.2%FY 2021: 7.3%FY 2022: -61.5%FY 2023: 67.0%FY 2024: -113.4%FY 2025: 349.3%
FY 2016 FY 2025
EPS (diluted) 334.8%
FY 2016: 134.3%FY 2017: -305.3%FY 2018: 76.1%FY 2019: 564.3%FY 2020: -283.8%FY 2021: 60.0%FY 2022: -73.8%FY 2023: 196.7%FY 2024: -65.1%FY 2025: 334.8%
FY 2016 FY 2025
Free Cash Flow 47.6%
FY 2016: 293.5%FY 2017: -165.8%FY 2018: -1.1%FY 2019: 2125.1%FY 2020: -116.4%FY 2021: -8.3%FY 2022: 4.3%FY 2023: 20.9%FY 2024: 5.4%FY 2025: 47.6%
FY 2016 FY 2025

Financial Health

Current Ratio 20.1×
FY 2016: 9.7×FY 2017: 7.0×FY 2018: 6.0×FY 2019: 10.3×FY 2020: 8.5×FY 2021: 8.6×FY 2022: 8.1×FY 2023: 9.0×FY 2024: 10.0×FY 2025: 20.1×
FY 2016 5y median 9.0× FY 2025
Quick Ratio 20.0×
FY 2016: 9.7×FY 2017: 7.0×FY 2018: 6.0×FY 2019: 10.3×FY 2020: 8.5×FY 2021: 8.5×FY 2022: 8.0×FY 2023: 8.8×FY 2024: 9.8×FY 2025: 20.0×
FY 2016 5y median 8.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: 119×FY 2017: 10.5×FY 2018: 44.7×FY 2019: -4.8×FY 2020: 7.2×FY 2021: 21.7×FY 2022: -126×FY 2023: -3.1×FY 2024: -1.2×FY 2025: -0.2×
FY 2016 5y median -1.2× FY 2025
Interest Coverage 212×
FY 2016: -244×FY 2017: -95.9×FY 2018: -57.4×FY 2019: 284×FY 2020: -19.0×FY 2021: -14.2×FY 2022: -38.4×FY 2023: -53.4×FY 2024: -598×FY 2025: 212×
FY 2016 5y median -38.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31